Tratamento de Cancro do fígado em Israel — receba 3 correspondências de clínicas personalizadas

Israeli oncology centres report success rates between 85% and 95% for surgical removal of early-stage liver tumours. Leading facilities like Sourasky Medical Center maintain a 90% overall oncology treatment success rate. High-volume surgery and precision techniques help maintain these surgical outcomes.

• Procedure efficacy: Liver resection achieves 90% primary effectiveness for localized primary or metastatic tumours.
• Hepatic recovery: Institutions like Hadassah Medical Center report 80% post-surgical liver function recovery rates.
• Surgical volume: Sheba Medical Center manages 6,500+ liver cases annually to optimise survival curves.
• Expertise level: Top surgeons such as Dr Ido Nachmany specialise in robotic and laparoscopic liver management.

Bookimed Expert Insight: Israeli surgical success often stems from aggressive conversion therapies for complex cases. Programs like Hepatic Artery Infusion convert 80% of inoperable tumours into resectable ones. This means patients previously told they are ineligible for surgery may find options at high-volume centres like Sheba or Sourasky.

Patient Consensus: Patients emphasize that success involves long-term monitoring rather than just clinic discharge. They suggest arranging local follow-up in Australia before traveling to Israel, as scan-based checks for 24 months are the true test of surgery.

Patients choose Israel to confirm liver cancer diagnoses due to ultra-precise histopathology re-evaluations and multidisciplinary tumor boards. Centres like Sheba Medical Center use advanced PET/CT imaging and multi-omics testing. Australian patients gain clarity on staging through experts trained at prestigious US institutions within 3 to 4 days.

• Histopathology revision: Experts re-examine existing biopsy slides to rule out staging errors or misdiagnoses.
• Advanced imaging: Clinics use high-resolution PET/MRI and 256-slice CT scans to find microscopic lesions.
• Multidisciplinary boards: Hepatologists and surgeons at Sourasky Medical Center review cases collectively for accuracy.
• Molecular profiling: Specialist labs map genetic markers to match tumours with targeted immunotherapy protocols.

Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky manage massive patient volumes, treating over 1,800,000 people annually. This high-frequency exposure means their specialists, like Professor Ido Nachmany, see rare liver variants daily. For Australians, this volume-driven expertise often results in reinterpreted staging that may prevent unnecessary invasive surgeries.

Patient Consensus: Patients find the speed of bundled appointments for scans and pathology reviews provides immense psychological relief. They emphasize bringing original digital scans and biopsy slides to Israel to ensure a fast, fresh perspective on their condition.

Cirrhosis significantly restricts liver cancer treatment because it limits the liver's ability to process drugs and heal after surgery. Specialists in Israel use MELD or Child-Pugh scores to assess liver reserve. High-scoring cases often require liver-sparing therapies like radiofrequency ablation or chemoembolisation instead of major surgery.

• Treatment selection: Liver reserve determines eligibility for curative options like resection or transplant.
• Surgical risks: Scarring increases bleeding hazards and complicates recovery after tumour removal.
• Sparing techniques: Specialists use CyberKnife or ablation to treat tumours while protecting functional tissue.
• Drug metabolism: Impaired filtration requires precise chemo dosing to avoid toxicity and liver failure.

Bookimed Expert Insight: Israeli oncology centres like Sourasky often prefer local-regional therapies over systemic chemotherapy for cirrhotic patients. Data shows specialists there, such as Professor Ido Nachmany, specialise in robotic liver surgeries. These minimally invasive techniques help preserve the small amount of healthy liver tissue remaining in cirrhotic patients.

Patient Consensus: Patients note that liver function scores often dictate treatment more than the tumour size itself. They emphasize that while major surgery is frequently ruled out, alternatives like TACE or ablation in Israel provide effective, liver-sparing options.

A biopsy is not always required for liver cancer treatment in Israel. Following international guidelines, Israeli oncologists often diagnose hepatocellular carcinoma (HCC) using high-resolution imaging. This non-invasive approach is standard if patients have cirrhosis or chronic hepatitis and show specific vascular patterns on scans.

• Imaging diagnosis: Dynamic CT or MRI often confirms cancer via arterial-phase contrast uptake.
• Tumour markers: High Alpha-Fetoprotein levels combined with precise imaging can replace invasive needles.
• Biopsy criteria: Biopsies are necessary for non-cirrhotic patients or when imaging remains inconclusive.
• Seed avoidance: Skipping biopsies prevents tumour seeding and reduces risks like internal bleeding.

Bookimed Expert Insight: Israeli centres like Sourasky or Sheba often perform a histopathology revision for international cases. Patients should bring original pathology slides from Australia. This allows Israeli specialists to verify a previous biopsy without performing a second invasive procedure.

Patient Consensus: Patients in Israel note that doctors prefer using advanced imaging and blood markers to avoid biopsy risks. Many recommend disclosing any blood-thinning medications early to help the medical team safely plan diagnostic steps.

International patients typically stay in Israel between 4 days and 8 weeks. Quick diagnostics take 3 to 5 days. Minimally invasive liver procedures require 1 to 2 weeks. Complex surgeries or intensive therapies like CAR-T often need up to 2 months for safe recovery before flying.

• Diagnostic phase: Pre-treatment scans and biopsies usually take 2 to 4 days.
• Minimally invasive: Ablation or chemoembolisation stays range from 3 to 14 days.
• Surgical resection: Major liver surgery requires 2 to 3 weeks for clinical stability.
• Advanced therapies: Complex oncology treatments like CAR-T may require 4 to 8 weeks.

Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky serve over 1.8 million patients annually. Their high case volume allows doctors to streamline pre-treatment tests. Australian patients can often start treatment within 72 hours of arrival. This speed helps many complete complex surgical resections well within the 90-day tourist visa limit.

Patient Consensus: Patients note that the first few days are busy with scans and specialist reviews. They emphasize waiting for a formal fit-to-fly clearance before booking return flights to Australia. The medical teams in Israel routinely provide discharge summaries to ensure smooth transition of care to local GPs.

Leading liver cancer specialists in Israel include Prof. Nadir Arber, Dr. Sharon Pelles, and Prof. Ofer Merimsky at Sourasky Medical Center. Prof. Rifaat Safadi at Hadassah and Dr. Alexander Beny at Rambam also provide specialized care. These experts hold leadership roles in oncology and hepatology at top-tier academic hospitals.

• Surgical leadership. Dr. Joseph Klauzner chairs surgery at Sourasky, specializing in complex hepatobiliary procedures.
• Advanced therapies. Dr. Sharon Pelles performs liver resection and chemoembolization for advanced liver cancer.
• Research expertise. Prof. Nadir Arber has published 300+ papers, focusing on early cancer detection.
• International training. Prof. Tamar Jablonski-Perec trained at Memorial Sloan-Kettering, a premier New York cancer center.

Bookimed Expert Insight: While many patients seek out a single famous name, Bookimed data shows that better results come from specialists at JCI-accredited academic centers like Sourasky or Hadassah. These institutions provide integrated teams where surgeons and interventional radiologists work together on-site. Choosing a specialist who chairs a dedicated department often provides faster access to multidisciplinary tumor boards.

Patient Consensus: Patients value having a single coordinator to manage appointments and records across different specialties. Many found that submitting pathology reports early helped avoid treatment delays during their stay in Israel.

Top hepatobiliary specialists in Israel include Dr. Joseph Klauzner at Sourasky Medical Center and Dr. Menahem Ben-haim. These surgeons specialize in liver resection and complex Whipple procedures at JCI-accredited facilities. They often hold leadership roles in national oncology councils and international research societies.

• Dr. Joseph Klauzner. He chairs the surgery department at Sourasky – with 45+ years of clinical experience.
• Dr. Menahem Ben-haim. He specializes in complex liver cancer surgery and advanced tumor interventions at Sourasky.
• Dr. Rifaat Safadi. He leads the liver unit at Hadassah – and is a recognized hepatology researcher.
• Dr. Alexander Beny. He directs gastrointestinal services at Rambam – and uses combined medical and radiation oncology.

Bookimed Expert Insight: Patients seeking liver treatment in Israel benefit from a concentrated pool of experts at Sourasky Hospital. This center hosts specialists like Dr. Ido Wolf and Dr. Joseph Klauzner, who manage both medical and surgical oncology. This proximity allows for rapid multidisciplinary reviews, which are vital for aggressive liver malignancies.

Patient Consensus: Patients emphasize finding a team that coordinates surgery and pathology together in one location. Many felt more confident when their surgeon clearly explained the plan without rushing through the consultation.

Israeli liver cancer doctors offer expertise in advanced hepatobiliary surgery and medical oncology. They specialize in complex procedures like liver resections and chemoembolization. Many hold prestigious fellowships from institutions like Memorial Sloan-Kettering and UCLA. These credentials ensure they use research-backed methods for patient care.

• Surgical leadership. Prof. Joseph Klauzner has 45+ years of experience in complex gastrointestinal and pancreatic surgery.
• Advanced radiotherapy. Dr. Svetlana Zalmanova performs stereotactic radiosurgery, which targets liver tumors with high-precision radiation.
• Non-surgical interventions. Dr. Pelles Sharon specializes in chemoembolization and radiofrequency ablation for advanced tumors.
• Preventive focus. Prof. Nadir Arber leads research in early diagnosis, having published over 300 scientific papers.

Bookimed Expert Insight: Israeli specialists often hold dual certifications in medical and radiation oncology. For example, Dr. Alexander Beny at Rambam Medical Center provides integrated care by managing both chemotherapy and radiotherapy. This dual expertise allows for more cohesive treatment planning during a single consultation pathway.

Patient Consensus: Patients value the fast integration of imaging and surgery teams when deciding if a case is operable. They often seek second opinions here to confirm if advanced liver tumors can still be treated.

Israeli liver cancer doctors provide advanced minimally invasive procedures like robotic surgery and targeted tumor ablation. Specialists at JCI-accredited centers like Sheba and Sourasky use these small-incision techniques to reduce recovery times. Many doctors hold international fellowships and lead surgical oncology departments in Tel Aviv and Ramat Gan.

• Robotic resections. Prof. Ido Nachmany pioneered robotic oncologic resections to remove liver tumors with extreme precision.
• Tumor ablation. Dr. Pelles Sharon performs radiofrequency ablation, which uses heat to destroy localized cancer cells.
• NanoKnife therapy. Dr. Almog Ben Yaacov uses irreversible electroporation to treat tumors near sensitive bile ducts.
• Embolization techniques. Specialists offer chemoembolization to block blood flow to tumors while delivering targeted drug therapy.

Bookimed Expert Insight: Israeli specialists often combine surgical and radiation expertise for complex cases. For example, Dr. Alexander Beny is board-certified in both medical and radiation oncology. This dual certification allows doctors to craft more integrated plans, combining minimally invasive surgery with precise brachytherapy or stereotactic radiosurgery.

Patient Consensus: Patients usually undergo detailed imaging before doctors confirm if a minimally invasive approach is safe. Typical journeys involve discussing laparoscopic options or catheter-based treatments to avoid large abdominal scars.

Oncologists and radiologists in Israel lead multidisciplinary teams to manage liver cancer through systemic drugs and image-guided therapies. Specialists like Dr. Pelles Sharon from Sourasky Medical Center perform targeted chemoembolization while medical oncologists manage advanced immunotherapies to improve patient results.

• Systemic therapy management. Oncologists oversee immunotherapies and targeted drugs to treat advanced liver cancer.
• Targeted tumor destruction. Radiologists perform chemoembolization and radiofrequency ablation to destroy tumors without major surgery.
• Advanced radiation techniques. Dr. Svetlana Zalmanova at Assuta Medical Center uses stereotactic radiosurgery for precise tumor targeting.
• Treatment plan coordination. Specialists at Rambam and Ichilov review scans to determine if tumors are operable.

Bookimed Expert Insight: Israeli liver cancer care is unique because many specialists hold dual expertise in both medical and radiation oncology. For example, Dr. Alexander Beny at Rambam Medical Center is board-certified in both fields. This allows one doctor to integrate radiation and systemic treatments more smoothly into a single care plan.

Patient Consensus: Patients noticed that imaging results from radiologists directly triggered their next oncology appointment. They felt it was important to ask which specialist would handle their overall follow-up care. Early diagnosis was easier because centers often have a dedicated unit for cancer prevention.

A second opinion for liver cancer involves a detailed review of medical records by specialists like Dr. Ido Wolf at Sourasky Medical Center. Many leading experts offer virtual consultations to confirm diagnoses and suggest advanced therapies like chemoembolization without requiring immediate travel.

• Specialized records review. Specialists evaluate pathology slides and imaging to verify the cancer stage and type.
• Tailored treatment plans. Experts may recommend liver resection or targeted therapy based on the latest research.
• Virtual accessibility. Many doctors provide remote consultations, making expert advice accessible from any location.
• Formal assessment reports. Patients receive a detailed document outlining expert recommendations for their specific case.

Bookimed Expert Insight: Israeli specialists often provide second opinions that integrate surgical and medical oncology perspectives. For example, Prof. Dr. Ofer Merimsky at Sourasky Medical Center combines radiotherapy expertise with sarcoma-related liver cancer knowledge. This dual-specialty approach helps patients determine if they need complex surgeries or less intensive treatments.

Patient Consensus: Patients value the peace of mind that comes from having a specialist directly examine their original imaging and biopsy slides. They often find that clarifying required documents early helps speed up the review of their treatment plan.